Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Foundation to co-host event focused on patient reach alongside UNGA 2025

As investors and the pharmaceutical industry alike express a continued interest in aligning the measurement and reporting of patient reach, the Access to Medicine Foundation, PGIM and Jennison Associates will host an event on the sidelines of the 80th United Nations General Assembly (UNGA) to explore how the industry might evolve its approach to patient reach metrics.

Date

23 September 2025

Location

New York

In September 2025, the United Nations General Assembly (UNGA) will open its 80th session in New York, where the Foundation will host a series of events focused on identifying solutions to current access challenges and on sustainably improving the availability and affordability of essential healthcare products worldwide.

Among these events is a high-level, closed-door roundtable titled “Health equity event: Measuring & reporting patient reach", co-hosted in collaboration with PGIM and Jennison Associates. The event will convene senior representatives from pharmaceutical companies, institutional investors and access-to-medicine experts in an open forum held under the Chatham House Rule to discuss company strategies related to patient reach, or the number of people reached via companies’ access efforts. The roundtable will be structured around a series of thematic discussion rounds guided by key questions. These include: 

  • Round 1 – Methodology & scope: How can companies refine methods and reporting to fit different contexts and scenarios?  

  • Round 2 – From reporting to impact: How can companies set meaningful goals around impact, and demonstrate tangible progress towards these goals?  

  • Round 3 – Alignment with financial metrics: How can these metrics be meaningfully linked to financial strategy?

Other events in the series include a networking reception co-hosted with MedAccess and a roundtable discussion titled "Bridging the gap: Scaling innovative approaches to NCD medicine access in LMICs", co-hosted with the Medicines Patent Pool (MPP), NCD Alliance (NCDA) and NCD Policy Lab.

Research hub

Explore our research reports and publications
Research

Patient centricity: How is the pharma industry addressing patient reach?

10 September 2024
Research

2024 Access to Medicine Index

19 November 2024
Research

Tracking progress of access strategies against patient reach goals

19 November 2024

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved